- Correspondence Aug 31, 2022Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants
J. Malato and OthersDOI: 10.1056/NEJMc2209479 - Perspective Aug 31, 2022Intradermal Vaccination for Monkeypox — Benefits for Individual and Public Health
J.T. Brooks and OthersDOI: 10.1056/NEJMp2211311 - Review Article Aug 31, 2022Franklin H. Epstein Lecture: Covid-19 Vaccines — Immunity, Variants, Boosters
D.H. BarouchDOI: 10.1056/NEJMra2206573 - Original Article Aug 28, 2022Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator
P. Friedman and OthersDOI: 10.1056/NEJMoa2206485 - Editorial Aug 27, 2022Surveillance Stress Testing “POST-PCI” — A Future Class III Recommendation?
J.E. Tamis-HollandDOI: 10.1056/NEJMe2210021 - Editorial Aug 27, 2022DELIVERing Progress in Heart Failure with Preserved Ejection Fraction
K.B. MarguliesDOI: 10.1056/NEJMe2210177 - Editorial Aug 27, 2022REVIVE-ing a Weak Heart — Details Matter
A.J. KirtaneDOI: 10.1056/NEJMe2210183 - Editorial Aug 27, 2022Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease
G.Y.H. LipDOI: 10.1056/NEJMe2210187 - Original Article Aug 27, 2022Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
S.D. Solomon and OthersDOI: 10.1056/NEJMoa2206286 - Original Article Aug 27, 2022Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
D. Perera and OthersDOI: 10.1056/NEJMoa2206606 - Original Article Aug 27, 2022Routine Functional Testing or Standard Care in High-Risk Patients after PCI
D.-W. Park and OthersDOI: 10.1056/NEJMoa2208335 - Original Article Aug 27, 2022Oxygen Targets in Comatose Survivors of Cardiac Arrest
H. Schmidt and OthersDOI: 10.1056/NEJMoa2208686 - Original Article Aug 27, 2022Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest
J. Kjaergaard and OthersDOI: 10.1056/NEJMoa2208687 - Original Article Aug 27, 2022Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
S.J. Connolly and OthersDOI: 10.1056/NEJMoa2209051 - Editorial Aug 26, 2022New Decongestion Strategies in an Evolving Heart Failure Landscape
G.M. FelkerDOI: 10.1056/NEJMe2209997 - Editorial Aug 26, 2022The Polypill at 20 — What Have We Learned?
T.J. WangDOI: 10.1056/NEJMe2210020 - Original Article Aug 26, 2022Acetazolamide in Acute Decompensated Heart Failure with Volume Overload
W. Mullens and OthersDOI: 10.1056/NEJMoa2203094 - Original Article Aug 26, 2022Polypill Strategy in Secondary Cardiovascular Prevention
J.M. Castellano and OthersDOI: 10.1056/NEJMoa2208275 - Original Article Aug 26, 2022Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial
J.S. Lindholt and OthersDOI: 10.1056/NEJMoa2208681 - Perspective Aug 24, 2022Professional Civil Disobedience — Medical-Society Responsibilities after Dobbs
M.K. WyniaDOI: 10.1056/NEJMp2210192
